Research Article
Regional Fos expression induced by morphine withdrawal in the 7-day-old rat
Article first published online: 25 AUG 2009
DOI: 10.1002/dev.20392
Copyright © 2009 Wiley Periodicals, Inc.
Additional Information
How to Cite
McPhie, A. A. and Barr, G. A. (2009), Regional Fos expression induced by morphine withdrawal in the 7-day-old rat. Dev. Psychobiol., 51: 544–552. doi: 10.1002/dev.20392
Publication History
- Issue published online: 9 OCT 2009
- Article first published online: 25 AUG 2009
- Manuscript Accepted: 1 JUL 2009
- Manuscript Received: 5 JUL 2007
Funded by
- NIH. Grant Numbers: DA-06600, DA-00325, RR03037
- National Science Foundation
- CUNYAGEP fellowship
- Abstract
- References
- Cited By
Keywords:
- opiate;
- morphine;
- dependence;
- withdrawal;
- Fos;
- periaqueductal gray;
- nucleus accumbens;
- spinal cord;
- locus coeruleus
Abstract
Human infants are often exposed to opiates chronically but the mechanisms by which opiates induce dependence in the infant are not well studied. In the adult the brain regions involved in the physical signs of opiate withdrawal include the periaqueductal gray area, the locus coeruleus, amygdala, ventral tegmental area, nucleus accumbens, hypothalamus, and spinal cord. Microinjection studies show that many of these brain regions are involved in opiate withdrawal in the infant rat. Our goal here was to determine if these regions become metabolically active during physical withdrawal from morphine in the infant rat as they do in the adult. Following chronic morphine or saline treatment, withdrawal was precipitated in 7-day-old pups with the opiate antagonist naltrexone. Cells positive for Fos-like immunoreactivity were quantified within select brain regions. Increased Fos-like labeled cells were found in the periaqueductal gray, nucleus accumbens, locus coeruleus, and spinal cord. These are consistent with other studies showing that the neural circuits underlying the physical signs of opiate withdrawal are similar in the infant and adult. © 2009 Wiley Periodicals, Inc. Dev Psychobiol 51: 544–552, 2009.

1098-2302/asset/DEV_left.gif?v=1&s=de4a8863ac5f1ecdfa0b545e6a446f2f3a941009)
1098-2302/asset/cover.gif?v=1&s=4a069b6f43d9b9804bdeb72039c0a49c9bb5628f)